ZNQ:CA:TSX-BMO NASDAQ 100 Equity Index ETF (CAD)

ETF | US Equity |

Last Closing

CAD 87.07

Change

+1.83 (+2.15)%

Market Cap

CAD 0.91B

Volume

7.19K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+1.67 (+1.23%)

CAD 16.35B
ZSP:CA BMO S&P 500

+1.04 (+1.24%)

CAD 15.56B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.99 (+1.69%)

CAD 10.26B
VUN:CA Vanguard US Total Market

+1.36 (+1.33%)

CAD 9.10B
XUS:CA iShares Core S&P 500 Index ETF

+0.60 (+1.26%)

CAD 7.07B
HXS:CA Global X S&P 500 Corporate Cla..

+0.96 (+1.23%)

CAD 3.88B
VSP:CA Vanguard S&P 500 CAD hedged

+1.55 (+1.70%)

CAD 3.35B
QUU:CA Mackenzie US Large Cap Equity ..

+2.92 (+1.33%)

CAD 3.20B
XUU:CA iShares Core S&P US Total Mark..

+0.77 (+1.36%)

CAD 2.96B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+1.26 (+2.59%)

CAD 2.85B

ETFs Containing ZNQ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.85% 73% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.85% 71% C- 77% C+
Trailing 12 Months  
Capital Gain 35.31% 95% A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.31% 95% A 83% B
Trailing 5 Years  
Capital Gain 158.75% 100% F 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 158.75% 100% F 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 20.42% 100% F 86% B+
Dividend Return 20.45% 100% F 86% B+
Total Return 0.03% 2% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 22.55% 5% F 40% F
Risk Adjusted Return 90.71% 58% F 94% A
Market Capitalization 0.91B 65% D 68% D+

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.